Abstract
Cimetidine has been shown to have beneficial effects in colorectal cancer patients. In this study, a total of 64 colorectal cancer patients who received curative operation were examined for the effects of cimetidine treatment on survival and recurrence. The cimetidine group was given 800 mg day−1 of cimetidine orally together with 200 mg day−1 of 5-fluorouracil, while the control group received 5-fluorouracil alone. The treatment was initiated 2 weeks after the operation and terminated after 1 year. Robust beneficial effects of cimetidine were noted: the 10-year survival rate of the cimetidine group was 84.6% whereas that of control group was 49.8% (P<0.0001). According to our previous observations that cimetidine blocked the expression of E-selectin on vascular endothelium and inhibited the adhesion of cancer cells to the endothelium, we have further stratified the patients according to the expression levels of sialyl Lewis antigens X (sLx) and A (sLa). We found that cimetidine treatment was particularly effective in patients whose tumour had higher sLx and sLa antigen levels. For example, the 10-year cumulative survival rate of the cimetidine group with higher CSLEX staining, recognizing sLx, of tumours was 95.5%, whereas that of control group was 35.1% (P=0.0001). In contrast, in the group of patients with no or low levels CSLEX staining, cimetidine did not show significant beneficial effect (the 10-year survival rate of the cimetidine group was 70.0% and that of control group was 85.7% (P=n.s.)). These results clearly indicate that cimetidine treatment dramatically improved survival in colorectal cancer patients with tumour cells expressing high levels of sLx and sLa.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Adams WJ, Lawson J, Morris DL (1994) Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut 35: 1632–1636
Adams WJ, Morris DL (1994) Short-course cimetidine and survival with colorectal cancer. Lancet 344: 8939–9840 1768–1769
Charpin C, Bhan AK, Zurawski Jr VR, Scully RE (1982) Carcinoembryonic antigen (CEA) and carbohydrate determinant 19-9 (CA 19-9) localization in 121 primary and metastatic ovarian tumors: an immunohistochemical study with the use of monoclonal antibodies. Int J Gynecol Pathol 1: 231–245
Creagan ET, Ahmans DL, Green SJ, Long HJ, Frytak S, Itri M (1985) Phase II study of recombinant leukocyte A interferon (IFN-RA) plus cimetidine in disseminated malignant melanoma. J Clin Oncol 3: 977–981
Dohi T, Nemoto T, Ohta S, Shirata K, Hanai N, Nudelman E, Hakomori S, Ohsima M (1993) Different binding properties of three monoclonal antibodies to sialyl Le(x) glyciolipids in a gastric cancer cell line and normal stomach tissue. Anticancer Res 13: 1277–1282
Fukushi Y, Nudelman E, Levery SB, Hakomori S, Rauvala H (1984) Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). Biol Chem 259: 10511–10517
Fukushima K, Hirota M, Terasaki PI, Wakisaka A, Togashi H, Chia D, Suyama Y, Nudelman E, Hakomori S (1984) Characterization sialosylated Lewisx as a new tumor-associated antigen. Cancer Res 44: 5279–5285
Garcia-Caballero M, Neugebauer E, Rodriguez F, Castro N, Vera-Thorbeck C (1994) Histamine synthesis and content in benign and malignant breast tumors. Its effects on other host tissues. Surg Oncol 3: 167–173
Hansbrough JF, Zapata-Sirvent RL, Bender EM (1986) Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg 151: 249–255.7
Hellstrand K, Naredi P, Lindner P, Lundholm K, Rudenstam CM, Hermodsson S, Asztely M, Hafstrom L (1994) Histamine in immunotherapy of advanced melanoma: a pilot study. Cancer Immunol Immunother 9: 416–419
Hoff SD, Matsushita Y, Ota DM, Cleary KR, Yamori T, Hakomori S, Irimura T (1989) Increased expression of sialyl-dimeric Lex antigen in liver metastasis of human colorectal carcinoma. Cancer Res 49: 6883–6888
Hoff SD, Irimura T, Matsushita Y, Ota DM, Cleary KR, Hakomori S (1990) Metastatic potential of colon carcinoma: Expression of ABO/ Lewis-related antigens. Arch Surg 125: 206–209
Katoh J, Tsuchiya K, Sato W, Nakajima M, Iida Y (1996) Cimetidine and immunoreactivity. Lancet 348: 404–405
Kimura E, Koike T, Shimizu Y, Kodama M (1986) Complexes of the histamine H2-antagonist cimetidine with divalent and monovalent copper ions. Inorg Chem 25: 2242–2246
Kobayashi K, Matsumoto S, Morishima T, Kawabe T, Okamoto T (2000) Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression. Cancer Res 60: 3978–3984
Kumar A (1990) Cimetidine: an immunomodulator. Ann Pharmacother 24: 289–295
Matsumoto S (1995) Cimetidine and survival with colorectal cancer. Lancet 346: 115
Nakamori S, Kameyama M, Imaoka S, Furukawa H, Ishikawa O, Sasaki Y, Kabuto T, Imanaga T, Matsushita Y, Irimura T (1993) Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. Cancer Res 53: 3632–3637
Phillips ML, Nudelman E, Gaeta FCA, Perez M, Singhal AK, Hakomori S, Paulson JC (1990) ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl- Lex. Science 250: 1130–1132
Reynolds JL, Ahkter J, Morris DL (1996) In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines. Melanoma Res 6: 95–99
Sagaster P, Mikcksche M, Flamm J, Ludiwig H (1995) Randomized study using IFN-alpha versus IFN-alpha plus coumarin and cimetidine for treatment of advanced renal cell cancer. Ann Oncol 6: 999–1003
Shirata K, Hanai N, Yoshida H (1987) Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93. Cancer Res 47: 1267–1272
Srinivas U, Pahlsson P, Lundblad A (1996) E-selectin: sialyl Lewis a dependent adhesion of colon cancer cells is inhibited differently by antibodies against E-selectin ligands. Scand J Immunol 44: 197–203
Svendsen LB, Ross C, Knigge U, Frederiksen HJ, Graverse P, Kjaergard J, Luke M, Stimpel H, Sparso BH (1995) Cimetidine as an adjuvant treatment in colorectal cancer. Dis Colon Rectum 38: 514–518
Takada A, Ohmori K, Takahashi N, Tsuyuoka K, Yago A, Zenita K, Hasegawa A, Kannagi R (1991) Adhesion of human cancer cells to vascular endothelium mediated by carbohydrate antigen, sialyl Lewis A. Biochem Biophs Res Commun 179: 713–719
Takada A, Ohmori K, Yoneda T, Tsuyuoka K, Hasegawa A, Kiso M, Kannagi R (1993) Contribution of carbohydrate antigens sialyl Lewis-A and sialyl Lewis-X to adhesion of human cancer cells to vascular endothelium. Cancer Res 53: 354–361
Tonnesen H, Knigge U, Bulow S, Damm P, Fisherman K, Hasselfeldt P, Hjortrup A, Pedersen VM, Siemsson CJ, Svendsen LB, Christiansen PM (1988) Effect of cimetidine on survival after gastric cancer. Lancet 2: 990–992
Acknowledgements
We would like to thank K Saito for critical comments on the manuscript. We would also like to express our gratitude for cooperation of the Study Group of the Multicentre Clinical Study on cimetidine (Chair of Study Administration: S Matsumoto; Administrator, S Kodaira) involving 15 participating institutions (principal investigator): Fujita Health University, Second Teaching Hospital (S Matsumoto, S Umemoto), Fujita Health University Hospital (M Ochiai), Hamamatsu Medical School (S Baba), Hamamatsu Red Cross Hospital (K Okuda, M Sumiyama), Shizuoka Red Cross Hospital (J Miyata, K Ando), Toyota Chiiki Medical Centre (A Seto), Orido Hospital (K Takayama), Ooshima Hospital (K Nagai), Ootawara Red Cross Hospital (T Amemiya), Haga Red Cross Hospital (M Kojima), Mito Red Cross Hospital (M Sakuma), Saitama Chuo Hospital (K Maeda, Y Hosoda), Inagi City Hospital (E Kurihara), Kawasaki City Ida Hospital (S Sadahiro, H Kawahara), Teikyo University Hospital (S Kodaira). This work was supported in part by grants-in-aids for Scientific Research from the Ministry of Education, Science, Sports, and Culture and the Ministry of Health and Human Welfare in Japan.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matsumoto, S., Imaeda, Y., Umemoto, S. et al. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer 86, 161–167 (2002). https://doi.org/10.1038/sj.bjc.6600048
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6600048
Keywords
This article is cited by
-
Clinicopathological Features, Recurrence Patterns, and Prognosis of Pancreatic Adenocarcinoma with Normal Serum CA19-9. A Consecutive Series of 154 Cases from a Single Institute
Journal of Gastrointestinal Surgery (2020)
-
Inhibition of E-selectin expression on the surface of endothelial cells inhibits hepatocellular carcinoma growth by preventing tumor angiogenesis
Cancer Chemotherapy and Pharmacology (2016)
-
Enhancement of colonic anastomotic strength in rats by short-chain fatty acids
Techniques in Coloproctology (2010)
-
From carbohydrate leads to glycomimetic drugs
Nature Reviews Drug Discovery (2009)
-
Cytokine responses of intraepithelial lymphocytes are regulated by histamine H2 receptor
Journal of Gastroenterology (2009)